Literature DB >> 17133547

Rapid immunochromatographic test for hantavirus andes contrasted with capture-IgM ELISA for detection of Andes-specific IgM antibodies.

Maritza Navarrete1, Claudia Barrera, Luis Zaror, Carola Otth.   

Abstract

Hantavirus is associated with hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS). The clinical diagnosis of hantavirus infections has been confirmed routinely by the immunofluorescence antibody assay (IFA) or enzyme-linked immunosorbent assay (ELISA). A rapid and easy diagnostic test for hantavirus infection is required. A new immunochromatographic assay for hantavirus, POC-PUU, useful for the diagnosis of epidemic nephrophaty associated with hantavirus Puumala in Europe, was evaluated in Chile. This test is based on recombinant N-protein of hantavirus Puumala, and cross-reacts with other hantaviruses. Eighty human sera were selected at random from patients from Southern Chile who were suspected with HPS. The hantavirus capture-IgM ELISA was compared with a commercially available POC-PUU test (POC PUUMALA, Reagena Ltd., Toivala, Finland). The test sensitivity and specificity of the POC-PUU test were 97 and 90%, respectively. It is important to note that although the test is not specific for Andes virus the sensitivity and specificity were above 90%, which indicates good reactivity to the Puumala nucleoprotein antigen. As this test is cost-effective, with a high negative value, rapid and easy to carry out, specialized personnel are not necessary, nor does it require specialized equipment. Its usefulness for diagnosis is important in hospitals far from reference centers and areas with a high incidence of HPS cases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17133547     DOI: 10.1002/jmv.20759

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  Early diagnosis of hantavirus infection by family doctors can reduce inappropriate antibiotic use and hospitalization.

Authors:  Alette Brorstad; Kristina Bergstedt Oscarsson; Clas Ahlm
Journal:  Scand J Prim Health Care       Date:  2010-09       Impact factor: 2.581

Review 2.  A global perspective on hantavirus ecology, epidemiology, and disease.

Authors:  Colleen B Jonsson; Luiz Tadeu Moraes Figueiredo; Olli Vapalahti
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

Review 3.  Immune response during hantavirus diseases: implications for immunotherapies and vaccine design.

Authors:  Farides Saavedra; Fabián E Díaz; Angello Retamal-Díaz; Camila Covián; Pablo A González; Alexis M Kalergis
Journal:  Immunology       Date:  2021-03-18       Impact factor: 7.215

4.  Hantavirus pulmonary syndrome, Southern Chile, 1995-2012.

Authors:  Raúl Riquelme; María Luisa Rioseco; Lorena Bastidas; Daniela Trincado; Mauricio Riquelme; Hugo Loyola; Francisca Valdivieso
Journal:  Emerg Infect Dis       Date:  2015-04       Impact factor: 6.883

5.  Rapid enzyme-linked immunosorbent assay for the detection of hantavirus-specific antibodies in divergent small mammals.

Authors:  Karla Cautivo; Tony Schountz; Mariana Acuña-Retamar; Marcela Ferrés; Fernando Torres-Pérez
Journal:  Viruses       Date:  2014-05-06       Impact factor: 5.048

Review 6.  Hantavirus Induced Kidney Disease.

Authors:  Sheema Mir
Journal:  Front Med (Lausanne)       Date:  2022-01-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.